In-vitro Models for Studying Hepatitis C Virus
Author Information
Author(s): Ashfaq Usman Ali, Khan Shaheen N, Nawaz Zafar, Riazuddin Sheikh
Primary Institution: University of the Punjab, Lahore, Pakistan
Hypothesis
The development of in-vitro models can aid in the study and treatment of Hepatitis C Virus (HCV).
Conclusion
In-vitro models such as HCV sub-genomic replicons and infectious HCV culture systems are crucial for accelerating the development of anti-HCV drugs.
Supporting Evidence
- HCV infection affects 180 million people worldwide.
- Current treatments are costly and have significant side effects.
- Development of in-vitro models is essential for drug discovery.
Takeaway
Scientists are trying to create better ways to study the Hepatitis C virus so they can find new medicines to help people who are sick.
Methodology
The review summarizes various in-vitro models used to study HCV, including infection systems, sub-genomic replicons, and pseudoparticles.
Limitations
Current models may not fully replicate the complexity of HCV infection in humans, and some models are based on less common genotypes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website